Cargando…

Health economic evaluation of an mRNA high-risk human papillomavirus (HR-HPV) assay versus a DNA HR-HPV assay for the proposed French cervical screening programme

Population screening programmes must make good use of resources for the health system and users. To evaluate impacts of the type of diagnostic test in the new French cervical screening programme, an messenger ribonucleic acid (mRNA) high-risk human papillomavirus assay was compared to a deoxyribonuc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dombrowski, Caroline A., Weston, Georgie MF, Descamps, Pr Philippe, Izopet, Pr Jacques, Adams, Elisabeth J., Adams, Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302372/ https://www.ncbi.nlm.nih.gov/pubmed/35866838 http://dx.doi.org/10.1097/MD.0000000000029530

Ejemplares similares

Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation
por: Weston, Georgie, et al.
Publicado: (2020)

A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada
por: Weston, Georgie, et al.
Publicado: (2021)

Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population: Improved Specificity of the Cervista HPV HR Test by Changing the Cut-Off
por: Boers, Aniek, et al.
Publicado: (2014)

Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays
por: Dippmann, Carolin, et al.
Publicado: (2020)

Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework
por: Dhillon, Sharonjit K., et al.
Publicado: (2021)

Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda
por: Sinayobye, Jean d’Amour, et al.
Publicado: (2014)

Molecular characterization of high-risk human papillomavirus (HR-HPV) in women in Lomé, Togo
por: Kuassi-Kpede, Akouélé P., et al.
Publicado: (2021)

High-risk Human Papillomavirus (hrHPV) Prevalence and Genotype Distribution among Turkish Women
por: Gecer, Melin
Publicado: (2023)

Cytokine Release in HR-HPV(+) Women without and with Cervical Dysplasia (CIN II and III) or Carcinoma, Compared with HR-HPV([Formula: see text]) Controls
por: Bais, Aagje G., et al.
Publicado: (2007)

Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
por: Avian, Alice, et al.
Publicado: (2022)

Comparative study of a novel application of automated HR HPV assay and stability in a previously untested Preservative media
por: Morel, Mike E., et al.
Publicado: (2017)

Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology Results
por: Xue, Huifeng, et al.
Publicado: (2021)

A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results
por: Zhang, Yi, et al.
Publicado: (2023)

Correction: Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
por: Avian, Alice, et al.
Publicado: (2023)

ART is key to clearing oncogenic HPV genotypes (HR-HPV) in anal mucosa of HIV-positive MSM
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2019)

hrHPV E5 oncoprotein: immune evasion and related immunotherapies
por: de Freitas, Antonio Carlos, et al.
Publicado: (2017)

Determination and evaluation of HR-HPV genotype in different communities of Bihar, India
por: Parwez, Akhtar, et al.
Publicado: (2022)

Longitudinal analysis on the ecological dynamics of the cervicovaginal microbiome in hrHPV infection
por: Molina, Mariano A., et al.
Publicado: (2023)

Impact of HR-HPV infection on oncological outcomes in early cervical cancer
por: Su, Xiaoqiang, et al.
Publicado: (2023)

Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping
por: Kim, Moonsik, et al.
Publicado: (2022)

High-Risk Human Papillomavirus (HR-HPV) DNA Detection in Mouthwashes for Diagnosis of HPV-Driven Oropharynx Cancer and Its Curative Therapy—A Feasibility Study
por: Loermann, Gera, et al.
Publicado: (2022)

hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
por: Carozzi, F, et al.
Publicado: (2013)

LINE-1 and Alu Methylation in hrHPV-Associated Precancerous Cervical Samples
por: Chaiwongkot, Arkom, et al.
Publicado: (2022)

Development of high-throughput genotyping method of all 18 HR HPV based on the MALDI-TOF MS platform and compared with the Roche Cobas 4800 HPV assay using clinical specimens
por: Cai, Xushan, et al.
Publicado: (2019)

Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China
por: Wang, Lina, et al.
Publicado: (2016)

Distinct Patterns of Myeloid Cell Infiltration in Patients With hrHPV-Positive and hrHPV-Negative Penile Squamous Cell Carcinoma: The Importance of Assessing Myeloid Cell Densities Within the Spatial Context of the Tumor
por: Rafael, Tynisha S., et al.
Publicado: (2021)

An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping
por: Chan, Wai Sing, et al.
Publicado: (2020)

Assessing the Cervicovaginal Microbiota in the Context of hrHPV Infections: Temporal Dynamics and Therapeutic Strategies
por: Molina, Mariano A., et al.
Publicado: (2022)

Implication of high risk Human papillomavirus HR-HPV infection in prostate cancer in Indian population- A pioneering case-control analysis
por: Singh, Neha, et al.
Publicado: (2015)

Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework
por: Bhatia, Ramya, et al.
Publicado: (2023)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

Evaluation of 3D-CPA, HR-HPV, and TCT joint detection on cervical disease screening
por: Liang, Hui, et al.
Publicado: (2016)

Preferences and Experiences Regarding the Use of the Self-Sampling Device in hrHPV Screening for Cervical Cancer
por: Dieleman, Marjolein, et al.
Publicado: (2021)

Genotypic distribution of human papillomavirus and phylogenetic analysis of E6 and E7 gene of HR-HPV variants isolated from Pakistani population
por: Ahmed, Sameen, et al.
Publicado: (2023)

Distribution of cervical lesions in high-risk HPV (hr-HPV) positive women with ASC-US: a retrospective single-center study in China
por: Wang, Zhiling, et al.
Publicado: (2020)

Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection
por: Kim, Jinhee, et al.
Publicado: (2022)

Possible role of negative human papillomavirus E6/E7 mRNA as a predictor of regression of cervical intraepithelial neoplasia 2 lesions in hr-HPV positive women
por: Bruno, Maria Teresa, et al.
Publicado: (2022)

Cervical and Oral Screening for HR-HPV types 16 and 18 among Sudanese Women Cervical Lesions
por: Elasbali, Abdelbaset Mohamed, et al.
Publicado: (2012)

The integration of HR-HPV increases the expression of cyclins A and E in cytologies with and without low-grade lesions
por: Zubillaga-Guerrero, MI, et al.
Publicado: (2013)

Characteristics of the Cervicovaginal Microenvironment in Childbearing-Age Women with Different Degrees of Cervical Lesions and HR-HPV Positivity
por: ZHAI, QINGZHI, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i0sd44mev1nu3evg4tm0uirjgj